This page shows the latest BI news and features for those working in and with pharma, biotech and healthcare.
After starting ART, the patients also received bi-weekly doses of either vesatolimod or placebo as an add-on therapy, and then came off therapy while they were monitored for a
Boehringer Ingelheim took a different tack with its Alzheimer’s candidate BI 409306, which targeted PDE9, but that drug also failed mid-stage testing and was unable to show any improvement
That has built on NASH-focused deals dating back several years including a 2015 alliance with Pharmaxis for AOC3 inhibitor BI 1467335 – now discontinued – and a $201m agreement with gene-silencing
Repatha and Praluent are dosed more frequently – either monthly or bi-monthly.
Repatha and Praluent are dosed more frequently – either monthly or bi-monthly.
idecabtagene vicleucel) slated for approval next year, and other drugs including a bi-specific antibody from Amgen called AMG 420.
More from news
Approximately 4 fully matching, plus 94 partially matching documents found.
Since the initiative launched, AstraZeneca has seen two consecutive increases in the bi-annual employee engagement survey, with 69% of AstraZeneca employees agreeing that ‘Together, we are making progress in our
attractive and valuable bi-product.
Boehringer Ingelheim granted Amgen worldwide rights to BI 836909, a bispecific T cell engager designed to treat multiple myeloma. ... Under the agreement, Daiichi Sankyo will acquire a licence to Zymeworks' platforms to develop a bi-specific antibody
But you can deal with the other three factors. This is where Boehringer has a key strength because there is a very, very strong culture, which is built on our BI
1, 200. ZymeWorks (US). GSK (UK). License and option. Preclinical bi-specific antibodies based on Azymetric platform for treatment of solid tumours.
More from intelligence
Approximately 0 fully matching, plus 23 partially matching documents found.
AbbVie. ALK. Astellas. AstraZeneca. Bayer. Boehringer Ingelheim. BI. BMS. Celgene. Sanofi Genzyme.
CSL are a healthcare specialist business intelligence consultancy. We help companies utilise tools like Power BI &Tableau.
Offering Pharma companies a range of cost-effective ad hoc, interim or ongoing BI services (including GP practice Rx reports) and data Consultancy.
market in areas such as Incentive Compensation, KAM, Coaching, Collaboration platforms and BI sol.
In this paper, Ursula and Angela will show how they worked together on an initiative which would challenge the BI team’s comfort levels and capabilities, but ultimately elevate customer insights
More from PMHub
Approximately 1 fully matching, plus 10 partially matching documents found.
Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...